<DrugInformationSummary id="CDR0000816649"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Lazertinib works by blocking the activity of abnormal EGFR proteins that signal cancer cells to divide. This keeps cancer cells from growing and may kill them. Lazertinib can reach cancer cells in the brain, enabling it to treat cancers that have spread there. It is a type of targeted therapy drug called an EGFR tyrosine kinase inhibitor. </DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/lazertinib-mesylate-hydrate">Lazertinib Mesylate Hydrate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000792503">lazertinib mesylate hydrate</TerminologyLink><GlossaryLink ref="CDR0000816562">lazertinib mesylate hydrate</GlossaryLink><USBrandNames><USBrandName>Lazcluze</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>la-ZER-tih-nib MEH-zih-layt HY-drayt</TermPronunciation><MediaLink ref="CDR0000817415" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000817416" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c417f9ee-2027-4ed5-92ad-3c19266de16c&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Lazertinib Mesylate Hydrate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c417f9ee-2027-4ed5-92ad-3c19266de16c&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Lazertinib mesylate hydrate
         is approved to treat adults with:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000045323" dictionary="Cancer.gov" audience="Patient">non-small cell lung cancer</GlossaryTermRef></Strong> (NSCLC) that has spread to other parts of the body or cannot be removed by surgery and has an abnormal <GeneName><GlossaryTermRef href="CDR0000796876" dictionary="Cancer.gov" audience="Patient">EGFR</GlossaryTermRef></GeneName> gene. It is used with <GlossaryTermRef href="CDR0000805144" dictionary="Cancer.gov" audience="Patient">amivantamab</GlossaryTermRef> as the first treatment.</ListItem>
   </ItemizedList>
  
 </Section><Section id="_About"><Title>More About Lazertinib Mesylate Hydrate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792503">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.14">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a624058.html">Lazertinib Mesylate Hydrate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.15"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.16">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C210427">Find Clinical Trials for Lazertinib Mesylate Hydrate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2024-09-23</DateFirstPublished><DateLastModified>2024-12-03</DateLastModified></DrugInformationSummary>
